Related Experiment Video
Updated: Aug 15, 2026

Transurethral Instillation Procedure in Adult Male Mouse
Published on: November 2, 2017
Tamsulosin: the United States trials
1Division of Urology, University of Florida College of Medicine, Gainesville, USA.
Tamsulosin offers effective once-daily treatment for benign prostatic hyperplasia (BPH) symptoms, improving urinary flow rate in over half of patients within weeks. Its uroselective action minimizes cardiovascular side effects, but long-term use is necessary for sustained benefits.
Area of Science:
- Pharmacology
- Urology
Background:
- Benign prostatic hyperplasia (BPH) is a common condition in aging men.
- Obstructive symptoms significantly impact quality of life.
Purpose of the Study:
- To evaluate the efficacy and safety of tamsulosin for treating BPH.
- To determine the onset and duration of therapeutic effects.
Main Methods:
- Clinical assessment of urinary flow rate.
- Dosage titration from 0.4 mg to 0.8 mg daily.
- Monitoring for cardiovascular and PSA-related effects.
Main Results:
- Over 50% of patients experienced a >30% increase in peak urinary flow rate.
- Therapeutic effects observed within 2-3 weeks of reaching maximum dose.
- Tamsulosin demonstrated uroselective action with minimal cardiovascular impact and no effect on PSA levels.
Conclusions:
- Tamsulosin is an effective once-daily treatment for BPH.
- The medication provides rapid symptom relief and has a favorable safety profile.
- Indefinite treatment is required to maintain therapeutic benefits.
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Imaging Studies II: Ultrasonography
Imaging Studies III: Computed Tomography
Imaging Studies IV: Magnetic Resonance Imaging
Urodynamic Studies: Uroflowmetry

